Request Deal Involvement

Foresite Capital, Samsara BioCapital and venBio Partners led a $259m Series C round in Alumis.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

Red House Consulting

pr advisors

Red House Consulting

or

Principals

ALUMIS

target

ALUMIS

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

SR ONE LTD

bidder

SR ONE LTD

ALLY BRIDGE GROUP

bidder

ALLY BRIDGE GROUP

LILLY ASIA VENTURES

bidder

LILLY ASIA VENTURES

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

NEXTECH INVEST

bidder

NEXTECH INVEST

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

HBM HEALTHCARE INVESTMENTS

bidder

HBM HEALTHCARE INVESTMENTS

VENBIO LLC

bidder

VENBIO LLC

OMEGA FUNDS

bidder

OMEGA FUNDS

PIPER HEARTLAND HEALTHCARE CAPITAL

bidder

PIPER HEARTLAND HEALTHCARE CAPITAL

AYURMAYA CAPITAL

bidder

AYURMAYA CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Foresite Capital, Samsara BioCapital and venBio Partners led a $259m Series C round in Alumis.